Eucass 3AF 2022
  • Home
  • Conference
    • Mobile app
    • Official Program
    • Presentation
    • Program at-a-glance
    • Plenaries
    • Technical Session
    • Posters
    • Best Student Paper Award
    • Technical Committee
    • Organizing Local Committee
    • Technical visits
    • Technical visit registration form
  • Topics
  • Authors
    • Instructions to authors
  • Registration
    • Instructions to register
    • Registration form
    • Visa application et vaccination
    • Accommodation
    • Cancellation policy
  • Visibility
    • Become a Sponsor or an Exhibitor
    • Partners and Sponsors
    • Exhibitors
  • Venue
    • Your destination
    • Access
  • My account
  • Contacts
  • Home
  • Conference
    • Mobile app
    • Official Program
    • Presentation
    • Program at-a-glance
    • Plenaries
    • Technical Session
    • Posters
    • Best Student Paper Award
    • Technical Committee
    • Organizing Local Committee
    • Technical visits
    • Technical visit registration form
  • Topics
  • Authors
    • Instructions to authors
  • Registration
    • Instructions to register
    • Registration form
    • Visa application et vaccination
    • Accommodation
    • Cancellation policy
  • Visibility
    • Become a Sponsor or an Exhibitor
    • Partners and Sponsors
    • Exhibitors
  • Venue
    • Your destination
    • Access
  • My account
  • Contacts

Visa application et vaccination

For your visa demand:

https://france-visas.gouv.fr/en/web/france-visas/welcome-page

If you need a participation letter to get a visa for France, please contact the Conference Secretariat. Just specify the information requested for your visa demand (personal address, passport number).

About vaccination:

https://www.interieur.gouv.fr/covid-19-international-travel

Sanitary rules:

The vaccination schedule is considered complete 28 days after receiving one dose of Janssen vaccine, seven days after a second dose of other vaccines approved by the European Medicines Agency (namely Pfizer/Comirnaty, Moderna, AstraZeneca/Vaxzevria/Covishield) and, for persons who have received all the required doses of a WHO-licensed vaccine not approved by the European Medicines Agency, seven days after receiving an additional dose of a duly approved mRNA vaccine.

Since 1 February 2022, in order for their vaccination schedule to continue to be recognized as complete, persons aged 18 years or older wishing to enter French territory must have received a booster dose of messenger RNA vaccine no later than nine months after receiving the last mandatory dose.

EUCASS-3AF 2022

9th European Conference for Aerospace Sciences

For any technical request please contact:
Mr Christophe BONNAL
Senior Expert, CNES

christophe.bonnal@cnes.fr

For any other request please contact:
Mr Claude FOUBERT
Event Manager, VERT COM

 secretary@eucass-3af-2022.eu
Key dates

March 15th, 2022: Deadline to submit or modify an existing submission

By mid-April 2022: Notification to authors

By end of April 2022: Preliminary program

May 28th, 2022: Early bird fee deadline

July 1st, 2022: Full paper submission deadline

June 27th-July 1st 2022: Conference at Lille Grand Palais congress center

Partners & Sponsors
Social Media
Powered by VERT COM agency | Privacy policy